Mallinckrodt plc

Track this case

Case Number:

1:23-bk-11258

Court:

Delaware

Nature of Suit:

Firms

Companies

Sectors & Industries:

April 25, 2024
3rd Circ. Lets Mallinckrodt Off Sanofi's Royalty Hook

A Third Circuit panel said Thursday that Mallinckrodt PLC's Chapter 11 bankruptcy could sever its obligation to pay Sanofi-Aventis US LLC royalties on sales of an autoimmune disease drug, finding that Sanofi's contract to sell Mallinckrodt the rights to the drug created a claim ripe to be extinguished.
December 11, 2023
Sanofi Tells 3rd Circ. Post-Ch. 11 Drug Sales Triggered Deal

Sales of a drug that a Mallinckrodt PLC unit bought the rights for prior to its 2020 Chapter 11 bankruptcy should still trigger an obligation to pay the drug's originator royalties, since the deal allegedly survived the reorganization, an attorney for Sanofi Aventis told the Third Circuit on Monday.
October 10, 2023
Mallinckrodt Gets OK For New Chapter 11 Plan

A Delaware bankruptcy judge Tuesday overrode lender and equity holders' objections to Mallinckrodt PLC's Chapter 11 plan, clearing the way for the drugmaker to exit its second bankruptcy in three years.
October 04, 2023
Mallinckrodt Says Ch. 11 Was Needed Due To Debt Maturities

Bankrupt drugmaker Mallinckrodt told a Delaware judge Wednesday that its second Chapter 11 filing was a necessary step to address upcoming debt maturities, and its restructuring plan was a good-faith effort to deal with those obligations at a time when it was difficult to access credit markets.
September 27, 2023
Noteholders, Shareholders Call Mallinckrodt Ch. 11 Plan Unfair

Secured creditors and shareholders of Mallinckrodt are asking a Delaware bankruptcy judge to reject the Irish drugmaker's new Chapter 11 plan, saying they are being shortchanged in favor of unsecured opioid claimants and corporate directors.
September 20, 2023
Mallinckrodt Gets Final OK For $250M Ch. 11 Financing

Drugmaker Mallinckrodt received final approval Wednesday in Delaware bankruptcy court for $250 million of Chapter 11 financing from its prepetition secured lenders, despite one creditor's objection over proposed management bonuses.
August 30, 2023
Mallinckrodt Cleared To Tap Into $250M Of Ch. 11 Financing

Drugmaker Mallinckrodt PLC received permission Wednesday in Delaware bankruptcy court to tap into $250 million of Chapter 11 financing after the judge presiding over the case had his concerns about large fees owed to the lenders addressed by the debtor.
August 28, 2023
Mallinckrodt Files Second Ch. 11 To Wipe Out $1.9B Of Debt

Irish drugmaker Mallinckrodt PLC filed its second Chapter 11 case in three years in an effort to erase about $1.9 billion of secured debt in a follow-up restructuring case that comes after its earlier Chapter 11 addressed its legacy opioid liability.